Reinier G. Meester, MS, PhD

Freenome, Inc.

Poster(s):

• P2147 - Projected Benefit and Cost-Effectiveness of Offering a Choice of Blood-Based Screening Versus Existing Screening Tests for Colorectal Cancer in Two Real-World Settings
  Monday, October 28, 2024

  10:30 AM – 4:00 PM ET